'Pharma cos may post robust top-line growth in Q2'
Russia/CIS and Japan growth is likely to be muted given the rouble/yen depreciation versus the Indian rupee.
Oct 12, 2014, 12:39 PM IST
Russia/CIS and Japan growth is likely to be muted given the rouble/yen depreciation versus the Indian rupee.
Oct 12, 2014, 12:39 PM IST